Jackson O’Brien, Ph.D.Back to team
Dr. O’Brien joined Lincoln Park Capital in 2021 as a biotechnology analyst. Prior to joining, he developed proof-of-principle molecular computational devices to demonstrate and understand the computational capacity of biochemical systems as a graduate researcher at the University of Chicago’s Department of Physics (M.S 2017, Ph.D 2021). During his academic career, he collaborated with interdisciplinary teams of physicists, computer scientists, and chemical/biological engineers on primary research publications and presentations at international conferences. Currently, he covers biotechnology and therapeutics broadly with an emphasis on computational methodologies. He completed a B.S. with a double major in Physics and Mathematics at Butler University in 2016, graduating summa cum laude and Phi Beta Kappa.